Fund shareholders of Bio-Techne Corp
ISIN US09073M1045 · United States · LEI 54930073RLKQ51TILZ35
- Fund shareholders
- 604
- Of which ETFs
- 144 460 other funds
- Value held
- 4.5B $ 1.3M € · 56.6M SEK
- Share of capital
- 53.3 % of 156.6M shares on Apr 29, 2026
604 funds hold this company. This table lists the 603 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| BINDEX USA INDICE, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 183K € | 0.02 % | as of Dec 31, 2025 ↗ | ||
| ING DIRECT FONDO NARANJA STANDARD & POOR´S 500, FI AMUNDI IBERIA, SGIIC, S.A. | 173.2K € | 0.02 % | as of Dec 31, 2025 ↗ | ||
| BBVA BOLSA INDICE USA (CUBIERTO), FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 39K € | 0.02 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| DF DENT MIDCAP GROWTH FUND FORUM FUNDS | 3.96 % | as of Mar 31, 2026 ↗ |
| Brown Capital Management Small Company Fund Brown Capital Management Mutual Funds | 3.49 % | as of Mar 31, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 3.45 % | as of Feb 28, 2026 ↗ |
| Mairs & Power Small Cap Fund Trust for Professional Managers | 3.43 % | as of Mar 31, 2026 ↗ |
| Partners III Opportunity Fund Weitz Funds | 3.16 % | as of Mar 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 2.83 % | as of Mar 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 2.73 % | as of Apr 30, 2026 ↗ |
| DF DENT SMALL CAP GROWTH FUND FORUM FUNDS | 2.67 % | as of Mar 31, 2026 ↗ |
| Brown Advisory Small-Cap Growth Fund Brown Advisory Funds | 2.46 % | as of Mar 31, 2026 ↗ |
| Geneva SMID Cap Growth Fund Series Portfolios Trust | 2.37 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 596 | +36 | 83,338,417 | +12.0 % |
| 2026Q1 | 560 | -6 | 74,425,718 | +1.5 % |
| 2025Q4 | 566 | +1 | 73,334,853 | -0.7 % |
| 2025Q3 | 565 | -54 | 73,857,003 | -2.2 % |
| 2025Q2 | 619 | +22 | 75,541,354 | +1.5 % |
| 2025Q1 | 597 | +6 | 74,458,444 | -2.1 % |
| 2024Q4 | 591 | -28 | 76,063,406 | -5.6 % |
| 2024Q3 | 619 | -8 | 80,539,224 | +0.1 % |
| 2024Q2 | 627 | +6 | 80,476,636 | +6.5 % |
| 2024Q1 | 621 | +2 | 75,550,729 | -2.6 % |
| 2023Q4 | 619 | 77,578,448 |
Institutional managers
572 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 12,264,513 | 640.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 8,532,873 | 445.9M $ | as of Mar 31, 2026 |
| FMR LLC | 7,899,928 | 412.9M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 5,868,396 | 306.7M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 5,120,185 | 267.6M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 5,112,420 | 266.8M $ | as of Mar 31, 2026 |
| MAVERICK CAPITAL LTD | 4,739,721 | 247.7M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 4,588,706 | 239.8M $ | as of Mar 31, 2026 |
| Durable Capital Partners LP | 4,456,017 | 232.9M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 3,733,248 | 197.3M $ | as of Mar 31, 2026 |
| Ruane, Cunniff & Goldfarb L.P. | 3,392,001 | 177.3M $ | as of Mar 31, 2026 |
| NEUBERGER BERMAN GROUP LLC | 3,340,837 | 174.6M $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 3,188,210 | 166.6M $ | as of Mar 31, 2026 |
| UBS Group AG | 3,054,343 | 159.6M $ | as of Mar 31, 2026 |
| MAIRS & POWER INC | 2,750,282 | 143.7M $ | as of Mar 31, 2026 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2,462,487 | 128.7M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,447,331 | 127.9K $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 2,213,197 | 130.2M $ | as of Mar 31, 2026 |
| Sumitomo Mitsui Trust Group, Inc. | 2,054,294 | 107.4M $ | as of Mar 31, 2026 |
| DF DENT & CO INC | 2,043,047 | 106.8M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,973,136 | 103.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,943,534 | 101.6M $ | as of Mar 31, 2026 |
| SNYDER CAPITAL MANAGEMENT L P | 1,882,298 | 98.4M $ | as of Mar 31, 2026 |
| MACKENZIE FINANCIAL CORP | 1,779,636 | 93M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 1,759,119 | 91.9M $ | as of Mar 31, 2026 |
Declared shareholders of Bio-Techne Corp
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Capital Management | 7.38 % | 11,559,571 | as of Mar 31, 2026 · SCHEDULE 13G |
| FMR LLC and 1 other | 5.00 % | 7,859,928 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Bio-Techne Corp". https://titelia.com/en/stocks/bio-techne-corp-US09073M1045